Superworth

Haemonetics PE ratio HAE

Share price divided by earnings per share over the last twelve months, since 2011.

Today, Nov 2, 2026
58.9×
10-year median
51.6×
Against its 10-year history
61st
percentile: 0 is its lowest day, 100 its highest
10-year range
14.7× to 279×
Peer median
34.1×

Haemonetics' PE ratio is 58.9× as of Nov 2, 2026: a share price of $120.14 against $2.04 of earnings per share over the last twelve months.

That is above its ten-year median of 51.6×, close to the middle of its last ten years.

Over that time it ranged from 14.7× in Sep 2025 to 279× in Nov 2018.

The median for 10 medical instruments and supplies stocks of a similar size is 34.1×.

PE ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far58.9×14.9×58.9×
202523.5×14.7×33.2×
202432.2×29.4×39.8×
202334.3×31.9×53.8×
202247.4×47.2×148×
202188.4×26.5×99.9×
202057.4×43.1×89.4×
201989.2×89.2×252×
2018239×104×279×
2017129×121×139×
201664.6×61.2×64.6×
201565.8×63.5×134×
201467.4×43.3×70.6×
201371.7×40.8×104×
201239.2×22.4×40.2×
201122.1×18.8×22.1×

Against its peers

Companies in Medical - Instruments & Supplies nearest Haemonetics' size, closest first, today.

CompanyPE ratio
HAEHaemonetics58.9×
MMSIMerit Medical Systems31.7×
VNTVontier15.3×
BMIBadger Meter36.4×
MSAMSA Safety23.2×
ICUIICU Medical138×
NVSTEnvista42.6×
ATRCAtriCure285×
WRBYWarby Parker341×
PODDInsulet28.7×
GMEDGlobus Medical20.3×
Peer median34.1×

Where Haemonetics ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Haemonetics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.